Reuters logo
BRIEF-Blueprint Medicines reports Q4 loss per share $0.75
March 9, 2017 / 12:15 PM / 8 months ago

BRIEF-Blueprint Medicines reports Q4 loss per share $0.75

March 9 (Reuters) - Blueprint Medicines Corp

* Blueprint Medicines reports fourth quarter and full year 2016 financial results

* Q4 loss per share $0.75

* Q4 earnings per share view $-0.76 -- Thomson Reuters I/B/E/S

* Blueprint Medicines Corp- As of December 31, 2016, cash, cash equivalents and investments were $268.2 million, as compared to $162.7 million as of December 31, 2015

* Blueprint Medicines- Expects cash, cash equivalents and investments will be sufficient to enable it to fund its operating expensesm,cap ex needs into least late 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below